{"id":54066,"date":"2023-02-20T12:04:22","date_gmt":"2023-02-20T11:04:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\/"},"modified":"2023-02-20T12:04:22","modified_gmt":"2023-02-20T11:04:22","slug":"feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\/","title":{"rendered":"FeedKind\u00ae Protein Wins FDA GRAS Status for Use in Aquaculture"},"content":{"rendered":"
\n

SAN MATEO, Calif.–(BUSINESS WIRE)–Calysta, the world leader in fermented protein, has announced that its leading product, FeedKind\u00ae<\/sup>, has achieved generally recognized as safe (GRAS) status with the United States Food and Drug Administration (FDA).\n<\/p>\n

<\/a><\/p>\n

\nThe FDA\u2019s Center for Veterinary Medicine have granted Calysta\u2019s FeedKind protein GRAS status for use in the US in salmonid feeds at up to 18% of the diet. In the US FeedKind will be listed under its common name, dried fermentation biomass<\/i>.\n<\/p>\n

\nThe ruling means aquaculture companies in the US now have access to a nutritionally rich and non-GMO protein ingredient that both helps preserve biodiversity while addressing a growing market need for proteins for feed and food.\n<\/p>\n

\nAllan LeBlanc, VP and Aquaculture Lead at Calysta, said: \u201cWith so many exciting developments in US aquaculture, we are thrilled to be able to access this market. FeedKind protein is a perfect fit for the trout industry and the burgeoning recirculating aquaculture systems (RAS) industry for Atlantic salmon.<\/i>\n<\/p>\n

\n\u201cFeedKind is an exceptional alternative to other sources of protein, and is free from heavy metals, pesticides, and microplastics, ensuring animals are only fed the nutrients they need. Because it can be produced year-round using no arable land and without using any plant or animal ingredients, it truly is a protein without limits.\u201d<\/i>\n<\/p>\n

\nHerman Sloot, Vice President of Commercial Development, said: <\/b>\u201cUS GRAS status was a key achievement for us, so we are very pleased with the official notice. This brings the US closer in line with existing approvals in other markets throughout the world, such as the EU, and enables us to expand the market opportunity for this revolutionary product. This is an important first step in our path toward US GRAS status for use in pet foods to complement our existing EU and UK approvals for pet food.<\/i>\n<\/p>\n

\n\u201cGRAS status also means the world has an effective and nutritious option added to its toolbox as it comes to grips with the need to produce more food while protecting biodiversity for current and future generations. FeedKind has a far lower carbon footprint than conventional sources of animal protein and can help pet food and animal feed producers achieve their carbon reduction targets.\u201d<\/i>\n<\/p>\n

\nGRAS status comes after Calysta successfully switched on its first commercial-scale facility via Calysseo, its joint venture with animal feed giant Adisseo, providing 20,000 tonnes of protein for the Asian aquaculture market. Calysseo has already announced its intentions to expand its production footprint in the Kingdom of Saudi Arabia.\n<\/p>\n

\nFor more information, visit Calysta.com<\/a> or Feedkind.com<\/a>.\n<\/p>\n

\nAbout Calysta<\/b>\n<\/p>\n

\nCalysta, Inc.<\/a>, San Mateo, CA, is a biotechnology company working towards a future where the world\u2019s growing population has guaranteed food security. Calysta\u2019s aim is to make protein without limits by fermenting low cost, land free carbon sources, to create new feed and food products, creating sustainable, high value nutritional ingredients that don\u2019t interfere with the human food chain.\n<\/p>\n

\nFeedKind\u00ae,<\/sup><\/a> is made using very little water and no agricultural land by fermenting low cost, land free carbon sources, to create a safe, nutritious, traceable, and affordable protein. Produced via a natural fermentation, it is non-GMO, price competitive with existing sources of protein and produced to the highest quality standards. FeedKind\u00ae<\/sup> has been commercially validated through extensive customer trials in aquaculture and agriculture.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contacts<\/b>
Calysta Press Office: Calysta@webershandwick.com<\/a>
Steven Flanagan: SFlanagan@webershandwick.com<\/a>, (+44) 141 343 3250
\n
Sophie Newington: snewington@webershandwick.com<\/a> (+44) 203 353 8728
\n
Calysta Media Information: info@calysta.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN MATEO, Calif.–(BUSINESS WIRE)–Calysta, the world leader in fermented protein, has announced that its leading product, FeedKind\u00ae, has achieved generally recognized as safe (GRAS) status with the United States Food and Drug Administration (FDA). The FDA\u2019s Center for Veterinary Medicine have granted Calysta\u2019s FeedKind protein GRAS status for use in the US in salmonid feeds … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54066","6":"format-standard","7":"category-industry"},"yoast_head":"\nFeedKind\u00ae Protein Wins FDA GRAS Status for Use in Aquaculture - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FeedKind\u00ae Protein Wins FDA GRAS Status for Use in Aquaculture - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN MATEO, Calif.–(BUSINESS WIRE)–Calysta, the world leader in fermented protein, has announced that its leading product, FeedKind\u00ae, has achieved generally recognized as safe (GRAS) status with the United States Food and Drug Administration (FDA). The FDA\u2019s Center for Veterinary Medicine have granted Calysta\u2019s FeedKind protein GRAS status for use in the US in salmonid feeds ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-20T11:04:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230220005114\/en\/1717526\/21\/logo_calysta_color.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"FeedKind\u00ae Protein Wins FDA GRAS Status for Use in Aquaculture\",\"datePublished\":\"2023-02-20T11:04:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\\\/\"},\"wordCount\":586,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230220005114\\\/en\\\/1717526\\\/21\\\/logo_calysta_color.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\\\/\",\"name\":\"FeedKind\u00ae Protein Wins FDA GRAS Status for Use in Aquaculture - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230220005114\\\/en\\\/1717526\\\/21\\\/logo_calysta_color.jpg\",\"datePublished\":\"2023-02-20T11:04:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230220005114\\\/en\\\/1717526\\\/21\\\/logo_calysta_color.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230220005114\\\/en\\\/1717526\\\/21\\\/logo_calysta_color.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FeedKind\u00ae Protein Wins FDA GRAS Status for Use in Aquaculture\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FeedKind\u00ae Protein Wins FDA GRAS Status for Use in Aquaculture - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\/","og_locale":"en_US","og_type":"article","og_title":"FeedKind\u00ae Protein Wins FDA GRAS Status for Use in Aquaculture - Pharma Trend","og_description":"SAN MATEO, Calif.–(BUSINESS WIRE)–Calysta, the world leader in fermented protein, has announced that its leading product, FeedKind\u00ae, has achieved generally recognized as safe (GRAS) status with the United States Food and Drug Administration (FDA). The FDA\u2019s Center for Veterinary Medicine have granted Calysta\u2019s FeedKind protein GRAS status for use in the US in salmonid feeds ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-20T11:04:22+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230220005114\/en\/1717526\/21\/logo_calysta_color.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"FeedKind\u00ae Protein Wins FDA GRAS Status for Use in Aquaculture","datePublished":"2023-02-20T11:04:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\/"},"wordCount":586,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230220005114\/en\/1717526\/21\/logo_calysta_color.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\/","url":"https:\/\/pharma-trend.com\/en\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\/","name":"FeedKind\u00ae Protein Wins FDA GRAS Status for Use in Aquaculture - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230220005114\/en\/1717526\/21\/logo_calysta_color.jpg","datePublished":"2023-02-20T11:04:22+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230220005114\/en\/1717526\/21\/logo_calysta_color.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230220005114\/en\/1717526\/21\/logo_calysta_color.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/feedkind-protein-wins-fda-gras-status-for-use-in-aquaculture\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"FeedKind\u00ae Protein Wins FDA GRAS Status for Use in Aquaculture"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54066"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54066\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54066"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54066"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}